HTR1F and cancer: Given that immune checkpoint molecules have emerged as promising targets for cancer immunotherapy, the observed correlations suggest that HTR1F may be integrally linked to immune regulatory pathways within tumors, warranting further investigation into its role as a potential immunomodulatory factor and therapeutic target [36].